SCHEMBL10280237

SCHEMBL10280237

Cc1cccc(F)c1C(=O)Nc1ccc2c(c1)N(S(=O)(=O)c1cccc(N)c1)C[C@H](CO)O2

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5022579 0.95 RORC (0.70) RORC
SCHEMBL10280250 0.95 RORC (0.70) RORC
SCHEMBL10280247 0.91 RORC (0.79) RORC
SCHEMBL5021992 0.91 RORC (0.79) RORC
SCHEMBL10280233 0.90 RORC (0.66) RORC
SCHEMBL10280234 0.89 RORC (0.65) RORC
SCHEMBL15625835 0.88 RORC (0.84) RORC
SCHEMBL5022590 0.87 RORC (0.60) RORC
SCHEMBL5022507 0.87 RORC (0.70) RORC
SCHEMBL5022530 0.86 RORC (0.58) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012064744-A2 TETRAHYDROQUINOLINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORϒ ACTIVITY AND THE TREATMENT OF DISEASE LYCERA CORPORATION (US) 2012-05-18 WO disclosed